Ticker: RZLT

08:48am, Thursday, Dec 11, 2025

Rezolute Shares Tumble Nearly 90% After Key Phase 3 Trial Falls Short

Rezolute (NASDAQ:RZLT) stock sinks almost 90% as its Phase 3 sunRIZE trial for congenital hyperinsulinism fails to hit primary and secondary endpoints, despite some reduction in hypoglycemia events.